NANOEMULSION AS A DRUG DELIVERY SYSTEM OF ANTICANCER DRUG
Open Access
- 7 April 2025
- journal article
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- p. 82-94
Abstract
Nanoemulsions are isotropic systems made up of nanoscale droplets (about 200 nm in size) created by combining two immiscible liquids with the aid of emulsifiers. They are often regarded as harmless excipients and are made to enhance the release of active medicinal compounds. Improving drug distribution to specific areas is the main goal of employing nanoemulsions in cancer treatment. In addition to increasing bioavailability, nanoemulsions reduce adverse effects on healthy cells by encasing medications in a closed structure. This is especially crucial because, in the absence of such formulations, different medications fall short of their intended targets. The study shows that by increasing the solubility and bioavailability of anticancer medications, nanoemulsions can greatly improve their delivery. This is important because a lot of anticancer medications have low solubility, which reduces their ability to effectively target cancer cells. Nanoemulsions have been shown to effectively target tumor cells while minimizing the impact on healthy tissues. This targeted approach helps overcome the common issue of multidrug resistance seen in cancer treatments, as the nanoemulsions can be modified with specific ligands to focus on tumor cells. Targeting tumor cells and preventing multidrug resistance are two benefits of using nanoemulsions. Besides, hydrophilic and hydrophobic compounds can be encapsulated in nanoemulsions to satisfy a range of needs. Therefore, nanoemulsions are a promising new approach to cancer treatment. This review provides an overview of nanoemulsion in cancer therapeutics, aiming to highlight the current status of this technology.Keywords
This publication has 124 references indexed in Scilit:
- A phase I study of the ceramide nanoliposome in patients with advanced solid tumorsCancer Chemotherapy and Pharmacology, 2023
- Isolation and Culture of Mouse Hepatocytes and Kupffer Cells (KCs)2022
- Injectable nanoemulsions prepared by high pressure homogenization: processing, sterilization, and size evolutionApplied Nanoscience, 2018
- Excipient selection and aerodynamic characterization of nebulized lipid-based nanoemulsion loaded with docetaxel for lung cancer treatmentDrug Delivery and Translational Research, 2018
- EGFR Targeted Theranostic Nanoemulsion for Image-Guided Ovarian Cancer TherapyPharmaceutical Research, 2015
- Synthesis, characterization, biodistribution and scintigraphy of 99mTc-paclitaxel: a potential tracer of paclitaxelJournal of Radioanalytical and Nuclear Chemistry, 2014
- Enhancing the receptor-mediated cell uptake of PLGA nanoparticle for targeted drug delivery by incorporation chitosan onto the particle surfaceJournal of Nanoparticle Research, 2014
- Phosphatidylinositol 3-kinase Inhibitor (PIK75) Containing Surface Functionalized Nanoemulsion for Enhanced Drug Delivery, Cytotoxicity and Pro-apoptotic Activity in Ovarian Cancer CellsPharmaceutical Research, 2012
- Hyaluronan Oligomers-HPMA Copolymer Conjugates for Targeting Paclitaxel to CD44-Overexpressing Ovarian CarcinomaPharmaceutical Research, 2012
- ABC Transporters, Drug Resistance, and Cancer Stem CellsJournal of Mammary Gland Biology and Neoplasia, 2009